Skip to content

Effect of High-flow Nasal Oxygen Therapy Flow Rate in Patients with High Risk of Reintubation

Effect of High-flow Nasal Oxygen Therapy Flow Rate in Patients with High Risk of Reintubation: A Randomized, Crossover, Physiologic Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075248
Enrollment
Unknown
Registered
2023-08-30
Start date
2022-01-25
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory failure occurred after extubation

Interventions

Group 1:Orderly setting velocity of 40L/min,30L/min,50L/min, 40L/min
Group 2:Orderly setting velocity of 40L/min,50L/min,30L/min, 40L/min

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients were planning to undergo extubation and had one or more of the following high-risk factors for reintubation: (1) age>65 years old;(2) Heart failure was the cause of intubation;(3) moderate to severe chronic obstructive pulmonary disease;(4) APACHE II score on the day of extubation >12.(5) BMI>30 kg/m2;(6) airway obstruction;(7) poor ability to clear airway secretions;(8) difficult or delayed offline;(9) two or more pulmonary or cardiac or renal complications;(10) duration of mechanical ventilation more than 7 days.

Exclusion criteria

Exclusion criteria: (1) age< 18 years old;(2) hemodynamic instability (hypotension, mean arterial pressure <60 mmHg despite adequate blood volume and use of vasoactive agents);(3) evidence of pneumothorax on chest X-ray or computed tomography;(4) contraindications to electrical impedance tomography (EIT) (e.g., patients with implantable defibrillator);(5) inability to place an EIT electrode band (e.g., effect of wound dressing or thoracic drainage tube);(6) patients with tracheotomy;(7) patients who did not consent to participate in the study;(8) Other study protocols were enrolled.

Design outcomes

Primary

MeasureTime frame
Distribution of gas;

Secondary

MeasureTime frame
Lung injury markers;Blood gas analysis;

Countries

China

Contacts

Public ContactLiu Xiaoqing

The First Affiliated Hospital of Guangzhou Medical University

lxq1118@126.com+86 189 2886 8226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026